Summit Therapeutics SMMT
NASDAQ SMMT
$17.60 +0.48 (+2.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) EBT Margin (QoQ) (2017 - 2022)

Analysis

Summit Therapeutics (SMMT) EBT Margin (QoQ) (2017 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Summit Therapeutics 13.67 Bn 12.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -229,915.00
Jun 30, 2022 346,235.00
Mar 31, 2022 193,321.00
Dec 31, 2021 -929,916.00
Sep 30, 2021 4.13 Mn
Jun 30, 2021 -3.37 Mn
Mar 31, 2021 -177,752.00
Dec 31, 2020 250,289.00
Sep 30, 2020 -73,370.00
Jun 30, 2020 -673,448.00
Mar 31, 2020 562,377.00
Dec 31, 2019 -375,618.00
Oct 31, 2019 -131,834.00
Oct 31, 2018 -146,539.00
Jul 31, 2018 24,668.00
Apr 30, 2018 16,511.00
Jan 31, 2018 -25,157.00
Oct 31, 2017 732.00
Jul 31, 2017 24,905.00